Open Access NewsNews from the open access movement Jump to navigation |
|||
Paul Webster, Prescription for Canada: an unfettered medical journal, Globe and Mail, March 25, 2006. Excerpt:
It has been a month since the Canadian Medical Association, which represents 62,000 doctors, decided to freshen up its esteemed journal by firing the editor-in-chief, John Hoey, and his deputy, Anne Marie Todkill. Dr. Hoey and Ms. Todkill spent a decade transforming the bimonthly Canadian Medical Association Journal into one of the world's more respected scientific publications. On Thursday, a story they supervised was nominated for the coveted Michener Award for meritorious public service. Since their departure, the CMAJ has imploded. Citing confusion within the doctors' association over editorial independence -- something Dr. Hoey and Ms. Todkill recently accused it of violating -- eight senior and intermediate editors have resigned, along with 15 of the journal's 19 editorial board members. Many Canadian scientists who have published pioneering studies in the CMAJ on such issues as SARS and other infectious disease outbreaks are starting to wonder if it's healthy for the country's only major medical-science publication to belong to an association aimed at promoting special interests, however enlightened. The time has come, many researchers say, to rethink how to disseminate Canadian medical research. Support is growing for a fully independent, not-for-profit journal, free from owners with vested interests, and not reliant on advertising income. One of the ideas researchers are discussing is modelled on a series of journals published by Public Library of Science (PLoS), a San Francisco-based non-profit publisher launched in 2000 with support from almost 34,000 scientists and start-up financing from private foundations. PloS Biology, the most successful of the six Public Library of Science journals, already boasts having achieved more than twice as much measurable impact among scientists as the CMAJ does....Although CMAJ contents are free on-line, the journal is packed with pharmaceutical advertising, and is published by a holding company headed by a business executive. Many traditional journals now require that readers pay for on-line access, a development Dr. Hoey and Ms. Todkill pledged to resist before they were forced out....Alan Bernstein, a CMAJ board member who serves as president of the Canadian Institute for Health Research -- Ottawa's $800-million medical research agency -- has consulted PLoS president Harold Varmus on ways to increase access to publicly supported Canadian research.... Comment. CMAJ is already OA, so the move to PLoS would not be a conversion. It would only change the business model from reliance on advertising to reliance on processing fees paid, on the whole, by authors' research grants. The story is important for at least two reasons. It shows that the processing fee model can enhance editorial independence, not undermine it as some TA publishers have charged in the past. And the mainstream press is covering it. |